Park B, Liu G
Int J Mol Sci. 2020; 21(23).
PMID: 33271763
PMC: 7729741.
DOI: 10.3390/ijms21239152.
Zhang Q, Boisson B, Beziat V, Puel A, Casanova J
Mamm Genome. 2018; 29(7-8):603-617.
PMID: 30094507
PMC: 6317873.
DOI: 10.1007/s00335-018-9767-2.
Fan H, Huang L, Yang D, Lin Y, Lu G, Xie Y
Medicine (Baltimore). 2018; 97(14):e0215.
PMID: 29620631
PMC: 5902260.
DOI: 10.1097/MD.0000000000010215.
Hashemi H, Mohebbi M, Mehravaran S, Mazloumi M, Jahanbani-Ardakani H, Abtahi S
J Res Med Sci. 2017; 22:53.
PMID: 28567072
PMC: 5426098.
DOI: 10.4103/jrms.JRMS_1050_16.
Lawrence M
Curr Allergy Asthma Rep. 2015; 15(12):70.
PMID: 26492876
DOI: 10.1007/s11882-015-0574-5.
An update on the hyper-IgE syndromes.
Yong P, Freeman A, Engelhardt K, Holland S, Puck J, Grimbacher B
Arthritis Res Ther. 2012; 14(6):228.
PMID: 23210525
PMC: 3674633.
DOI: 10.1186/ar4069.
The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.
Szczawinska-Poplonyk A, Kycler Z, Pietrucha B, Heropolitanska-Pliszka E, Breborowicz A, Gerreth K
Orphanet J Rare Dis. 2011; 6:76.
PMID: 22085750
PMC: 3226432.
DOI: 10.1186/1750-1172-6-76.
B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.
Avery D, Deenick E, Ma C, Suryani S, Simpson N, Chew G
J Exp Med. 2010; 207(1):155-71.
PMID: 20048285
PMC: 2812540.
DOI: 10.1084/jem.20091706.
The hyper-IgE syndrome.
Buckley R
Clin Rev Allergy Immunol. 2001; 20(1):139-54.
PMID: 11269224
DOI: 10.1385/CRIAI:20:1:139.
Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens.
Leung D, Harbeck R, Bina P, Reiser R, Yang E, Norris D
J Clin Invest. 1993; 92(3):1374-80.
PMID: 7690780
PMC: 288279.
DOI: 10.1172/JCI116711.
Cutaneous defenses against dermatophytes and yeasts.
Wagner D, Sohnle P
Clin Microbiol Rev. 1995; 8(3):317-35.
PMID: 7553568
PMC: 174627.
DOI: 10.1128/CMR.8.3.317.
Mononuclear cells from patients with the hyperimmunoglobulin E-recurrent infection syndrome produce an inhibitor of leukocyte chemotaxis.
Donabedian H, Gallin J
J Clin Invest. 1982; 69(5):1155-63.
PMID: 7068851
PMC: 370180.
DOI: 10.1172/jci110551.
IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes.
Meretey K, Falus A, Bohm U, Permin H, Wiik A
Ann Rheum Dis. 1984; 43(2):246-50.
PMID: 6712297
PMC: 1001475.
DOI: 10.1136/ard.43.2.246.
Serum IgE and IgG antibodies to tetanus toxoid and candidin in immunodeficient children with the hyper-IgE syndrome.
Schmitt C, Ballet J
J Clin Immunol. 1983; 3(2):178-83.
PMID: 6602146
DOI: 10.1007/BF00915490.
Systemic lupus erythematosus in Staphylococcus aureus hyperimmunoglobulinaemia E syndrome.
Schopfer K, Feldges A, Baerlocher K, Parisot R, Wilhelm J, Matter L
Br Med J (Clin Res Ed). 1983; 287(6391):524-6.
PMID: 6411204
PMC: 1548449.
DOI: 10.1136/bmj.287.6391.524.
IgE induces secretion of prostaglandin E2 by human monocytes.
Passwell J, Geiger B, Levanon M, Davidsohn J, Cohen B, Ramot B
Clin Exp Immunol. 1984; 58(3):566-72.
PMID: 6334580
PMC: 1577113.
Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice.
Carlson E, Johnson G
Infect Immun. 1985; 50(3):655-9.
PMID: 3905609
PMC: 261128.
DOI: 10.1128/iai.50.3.655-659.1985.
Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A.
Dreskin S, Goldsmith P, Gallin J
J Clin Invest. 1985; 75(1):26-34.
PMID: 3871199
PMC: 423391.
DOI: 10.1172/JCI111683.
Abnormal humoral immune response to Staphylococcus aureus in patients with Staphylococcus aureus hyper IgE syndrome.
Matter L, Wilhelm J, Roth F, Schopfer K
Clin Exp Immunol. 1986; 66(2):450-6.
PMID: 3815899
PMC: 1542518.
The role of "allergy" in atopic dermatitis.
Sampson H
Clin Rev Allergy. 1986; 4(1):125-38.
PMID: 3516356
DOI: 10.1007/BF02991191.
